Adenocarcinoma

News Adenocarcinoma

• Abraxane plus gemcitabine improves survival in phase III study of patients with advanced pancreatic cancer

  Specialised Therapeutics Australia announced that a phase III clinical trial of breast cancer drug ABRAXANE® (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival t more

• Clavis Pharma announces negative outcome of pivotal LEAP Trial with CP-4126 in Patients with Metastatic Pancreatic Cancer

  Clavis Pharma ASA announced results of the LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CP-4126 (also known as CO-101), versus gemcitabine in metastatic pancreatic cancer. The trial, which was conducted by partner Clovis Oncology, Inc., showed that there was no difference in overall more

• Gene fusion in lung cancer afflicting never-smokers may be target for therapy

  Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked.  In a study published in Genome Research, researchers have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-sm more

Publications Adenocarcinoma

• Overexpression of Sulf2 in idiopathic pulmonary fibrosis

  Previously, we have shown that heparan sulfate (HS) 6-O-endosulfatase 1 (Sulf1) is a transforming growth factor-β1 (TGF-β1)-responsive gene in normal human lung fibroblasts and functions as a negative feedback regulator of TGF-β1 and that TGF-β1 induces the expression of Sulf1 as well as that of th more

• {beta}-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma

  Cancer stem-like cells (CSLC) are crucial in tumor initiation and progression; however, the underlying mechanism for the self-renewal of cancer cells remains undefined. In the study, immunohistochemical analysis of specimens freshly excised from patients with lung adenocarcinoma showed that high exp more

• PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

  Zhang L, Shi L, Zhao X, Wang Y, Yue W more

Market studies Adenocarcinoma

• Adenocarcinoma – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Adenocarcinoma - Pipeline Review, H2 2012', provides an overview of the Adenocarcinoma therapeutic pipeline. This report provides information on the therapeutic development for Adenocarcinoma, complete with latest updates, and special features on late-stage a more

• Lung Adenocarcinoma – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Lung Adenocarcinoma - Pipeline Review, H2 2012', provides an overview of the Lung Adenocarcinoma therapeutic pipeline. This report provides information on the therapeutic development for Lung Adenocarcinoma, complete with latest updates, and special features more

• Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2012', provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction therapeutic pipeline. This report provides information on the therapeutic development for Adenocarcinoma O more

Websites Adenocarcinoma